Although not well characterized in prostate cancer specifically, direct PTEN loss in several immune cell types, including regulatory T cells, natural killer cells and macrophages, has also been demonstrated to shift the TME to an immunosuppressive state in various cancer models (reviewed in [360,361]). Here, PTEN is linked to prostate cancer.